ReviewSkin health and disease2026

Efficacy and safety of two interleukin-17 inhibitors (bimekizumab and secukinumab) in the management of hidradenitis suppurativa: a systematic review and meta-analysis of randomized controlled trials.

Hana Ishkirat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.